On ECHEMI
Home > Drugs > Sinopharm Group Xinjiang Pharmaceutical Co., Ltd.
Sinopharm Group Xinjiang Pharmaceutical Co., Ltd.
  • Founded in:

    1984-08-01
  • Country:

    China China
  • Address:

    No. 21, Shaping West Street, Industrial Park, Urumqi Economic and Technological Development Zone (Touhunhe District), Xinjiang (China (Xinjiang) Pilot Free Trade Zone)
  • Tax NO.:

    9165010022866273X3
  • Registered Funds:

    90.964 million yuan
  • Website:

  • Email:

Related Drugs
Perphenazine tablets
The main ingredient of this product is perphenazine, and its chemical name is: 4-[3-(2-chlorophenothiazin-10-yl)propyl]-1-piperazineethanol.
Name Description Content CAS NO. Registered Holders
Prochlorperazine

The antipsychotic effect is mainly related to its blocking of dopamine receptors (DA2) in the mesolimbic system and mesocortical pathways related to emotional thinking, while blocking the alpha-adrenaline receptors in the reticular formation ascending activation system is related to the sedative and tranquilizing effect. This product has a strong antiemetic effect and a weak sedative effect.

More

The antipsychotic effect is mainly related to its blocking of dopamine receptors (DA2) in the mesolimbic system and mesocortical pathways related to emotional thinking, while blocking the alpha-adrenaline receptors in the reticular formation ascending activation system is related to the sedative and tranquilizing effect. This product has a strong antiemetic effect and a weak sedative effect.

58-38-8 9
Lidocaine Hydrochloride Injection
The main ingredient of this product is lidocaine hydrochloride. Its chemical name is N-(dichloroxylyl)-2-(diethylamino)acetamide hydrochloride monohydrate.
Name Description Content CAS NO. Registered Holders
Lidocaine hydrochloride

This product is an amide local anesthetic. After blood absorption or intravenous administration, it has obvious biphasic effects of excitation and inhibition on the central nervous system, and there may be no precursor excitation. When the blood concentration is low, analgesia and drowsiness occur, and the pain threshold increases; with increasing doses, the effect or toxicity increases, and it has an anticonvulsant effect at sub-toxic blood concentrations; convulsions may occur when the blood concentration exceeds 5μg·ml-1. At low doses, it can promote the outflow of K in myocardial cells, reduce the autonomy of the myocardium, and have an anti-ventricular arrhythmia effect; at therapeutic doses, it has no obvious effect on the electrical activity of myocardial cells, atrioventricular conduction, and myocardial contraction; further increases in blood concentrations can cause a slowing of the heart conduction velocity, atrioventricular conduction block, inhibition of myocardial contractility, and a decrease in cardiac output.

More

This product is an amide local anesthetic. After blood absorption or intravenous administration, it has obvious biphasic effects of excitation and inhibition on the central nervous system, and there may be no precursor excitation. When the blood concentration is low, analgesia and drowsiness occur, and the pain threshold increases; with increasing doses, the effect or toxicity increases, and it has an anticonvulsant effect at sub-toxic blood concentrations; convulsions may occur when the blood concentration exceeds 5μg·ml-1. At low doses, it can promote the outflow of K in myocardial cells, reduce the autonomy of the myocardium, and have an anti-ventricular arrhythmia effect; at therapeutic doses, it has no obvious effect on the electrical activity of myocardial cells, atrioventricular conduction, and myocardial contraction; further increases in blood concentrations can cause a slowing of the heart conduction velocity, atrioventricular conduction block, inhibition of myocardial contractility, and a decrease in cardiac output.

6108-05-0 45
Yupingfeng Oral Liquid
Astragalus, Saposhnikovia divaricata, and Atractylodes macrocephala (fried).
Name Description Content CAS NO. Registered Holders
Astragali Radix

0
SAPOSHNIKOVIAE RADIX

0
Atractylodes macrocephala (fried)

0
Vitamin Phosphate Calcium Tablets
This product is a compound preparation. Each tablet contains 160 mg of calcium gluconate (equivalent to 14.4 mg of calcium), 9.2 mg of calcium hydrogen phosphate (equivalent to 2.1 mg of calcium), 2 mg of sodium glycerophosphate, 0.096 mg of vitamin B2, and 2.25 micrograms of vitamin D2.
Name Description Content CAS NO. Registered Holders
CALCIUM GLUCONATE MONOHYDRATE

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability

14.4mg 66905-23-5 35
Calcium phosphate dibasic

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability

2.1mg 7757-93-9 16
Sodium 3-phosphoglycerate

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability

2mg 17603-42-8 9
Riboflavin

Essential substances for maintaining normal metabolism and growth and development of the body

More

Essential substances for maintaining normal metabolism and growth and development of the body

0.096mg 83-88-5 19
Vitamin D2

Essential substances for maintaining normal metabolism and growth and development of the body

More

Essential substances for maintaining normal metabolism and growth and development of the body

2.25microgram 50-14-6 13
Licorice Zinc Capsules
The main ingredient of this product is a zinc-containing drug that is a combination of an active ingredient extracted from the root of the legume plant licorice and zinc.
Name Description Content CAS NO. Registered Holders
Active ingredients extracted from licorice root

Increase the glucosamine content of gastric mucosal cells, improve the defense of gastric mucosa, prolong the life of gastric epithelial cells, and accelerate the healing of ulcers

More

Increase the glucosamine content of gastric mucosal cells, improve the defense of gastric mucosa, prolong the life of gastric epithelial cells, and accelerate the healing of ulcers

0
ZINC

Promote mucosal regeneration and accelerate ulcer healing

More

Promote mucosal regeneration and accelerate ulcer healing

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.